Following a ‘satisfactory’ H1 15, William Demant continued its steady pace in Q3 (qualitative update devoid of financial details), particularly in its core Hearing aids business which reported organic growth above the market growth rate of c.4-5% (volume growth), driven by the positive reception to its new Inium Sense platform. However, while the retail hearing aids market reported some recovery (particularly in the key market of North America), Diagnostic Instruments and Hearing
10 Dec 2015
Satisfactory Q3 but read-across on Hearing Implants concerning
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Satisfactory Q3 but read-across on Hearing Implants concerning
Following a ‘satisfactory’ H1 15, William Demant continued its steady pace in Q3 (qualitative update devoid of financial details), particularly in its core Hearing aids business which reported organic growth above the market growth rate of c.4-5% (volume growth), driven by the positive reception to its new Inium Sense platform. However, while the retail hearing aids market reported some recovery (particularly in the key market of North America), Diagnostic Instruments and Hearing